Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Recruiting NCT05618626

Prevention of NAFLD and CVD Through Lifestyle Intervention

Conditions: Non-Alcoholic Fatty Liver Disease, Gallstone Disease

Sex: All

Ages: 45 Years – 60 Years

Healthy volunteers: 1

Phase: NA

Enrollment: 300

Sponsor: Pontificia Universidad Catolica de Chile

Location: Chile

Summary

Prevention of non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease (CVD) through lifestyle intervention (MAUCO+) is a clinical trial that aims to improve sarcopenia, aerobic capacity, body composition, and lipid profile, insulin resistance, cardiovascular risk, NAFLD, and maintain a healthier lifestyle. Through the implementation of physical activity and nutritional programs.

Eligibility Criteria

Inclusion Criteria:With and without gallstones diseaseWith various degrees of NAFLD (none too severe)Exclusion Criteria:Any significant comorbidity or physical limitation to undergo resistance exercise programUse of medications that alter muscle mass (e.g., corticosteroids)History of hepatitis B or CUse of hepatotoxic drugs

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05618626). StuddyBuddy aggregates publicly available trial information.